Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Shum Steve, Chief Executive Officer. Insider active across 3 companies, notably INVO Bioscience, Inc.. Aggregated, 7 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €139k. Activity tracked since 5 October 2021. The latest transaction was filed on 31 July 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Steve Shum is Directeur Général. He has 7 filings in total. In the recent filings available, they cover the period from 2021-10-07 to 2025-08-01, with EUR 138740 of buys and EUR 0 of sells, and the modal transaction nature is Attribution. He is also listed as Chief Executive Officer at INVO Bioscience, Inc., and Director at Expion360 Inc. and CalEthos, Inc.